通过X77抑制HCoV-NL63主要蛋白酶Mpro的结构基础
Jie Xu1, Qinyao Zhu2, Wenwen Li3
1Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Biochemical and biophysical research communications
|June 9, 2024
概括
研究人员研究了人类冠状病毒NL63主要蛋白酶 (Mpro) 以及它与抑制剂X77.7的相互作用. 这项研究为开发针对人类冠状病毒的广泛抗病毒药物提供了结构性见解.
科学领域:
- 病毒学 病毒学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 人类冠状病毒引起呼吸道和肠道疾病,并导致严重的并发症.
- 主蛋白酶 (Mpro) 对于病毒复制至关重要,也是药物开发的目标.
- 随着COVID-19的流行,广泛的抗病毒疗法的研究得到了加剧.
研究的目的:
- 为了阐明HCoV-NL63 Mpro与抑制剂X77.7复合的晶体结构.
- 分析HCoV-NL63 Mpro和X77.7之间的详细相互作用.
- 为了比较X77与SARS-CoV-2 Mpro和HCoV-NL63 Mpro的结合方式.
主要方法:
- 进行X射线晶体学以确定复杂的结构.
- 分子对接模拟用于预测结合相互作用.
- 抑制剂结合的比较结构分析.
主要成果:
- 解决了HCoV-NL63 Mpro-X77复合物的晶体结构.
- 对相互作用的详细分析揭示了特定的结合模式和决定因素.
- 对比突出了X77与不同冠状病毒Mpro酶结合的相似之处和差异.
结论:
- 这项研究提供了关于HCoV-NL63 Mpro受X77.7抑制的关键结构信息.
- 这些见解对于设计针对保存的Mpro活性位点的新型抑制剂至关重要.
- 这些发现支持开发针对人类冠状病毒的广泛抗病毒药物.
相关概念视频
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


